Search
Search
About
Log in
Join
Experiences with
Trastuzumab
Posts
Communities
87 public posts
Filter results
Weekly Paclitaxel protocol
Herceptin -
Trastuzumab
150mg (weekly) for 52 weeks. No prior anthracyclin or any other chemotherapy was given to her. She has completed 1st three chemo sessions (weekly) successfully, but there was drop in WBC count.
Herceptin -
Trastuzumab
150mg (weekly) for 52 weeks. No prior anthracyclin or any other chemotherapy was given to her. She has completed 1st three chemo sessions (weekly) successfully, but there was drop in WBC count.
anshul_15
in
Breast Cancer India
9 years ago
Some Breast Cancer Survivors Feel Like 'New Species'
Shirley Mertz, president of the US Metastatic Breast Cancer Network, who has been living with metastatic breast cancer since 2003, said those she refers to as "long-term responders" have lived long enough to see second- and third-line treatments such as
trastuzumab
approved for human epidermal growth
Shirley Mertz, president of the US Metastatic Breast Cancer Network, who has been living with metastatic breast cancer since 2003, said those she refers to as "long-term responders" have lived long enough to see second- and third-line treatments such as
trastuzumab
approved for human epidermal growth
roxboxfox
RadiationOncologist
in
Breast Cancer India
9 years ago
Dr. Richard Isaacs, MD: Big Pharma has the upper hand and they know it
As two more options came onto the market - Docetaxel, also in 2002, and
Trastuzumab
, in 2007 - list prices rose to $2488 and $5300 respectively. A similar trend was also shown across medicines for the treatment of kidney cancer, and lung cancer, rising 411 and 44 per cent respectively.
As two more options came onto the market - Docetaxel, also in 2002, and
Trastuzumab
, in 2007 - list prices rose to $2488 and $5300 respectively. A similar trend was also shown across medicines for the treatment of kidney cancer, and lung cancer, rising 411 and 44 per cent respectively.
behr3ndsue
in
Health Walk
9 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Is phase IV chemotherapy trial good to take ?
Details of trial: Protocol Number: ML28714 Study Title: AN INDIAN MULTICENTRIC OPEN LABEL PROSPECTIVE PHASE IV STUDY TO EVALUATE SAFETY AND EFFICACY OF
TRASTUZUMAB
IN HER2 POSITIVE, NODE POSITIVE OR HIGH RISK NODE NEGATIVE BREAST CANCER AS A PART OF TREATMENT REGIMEN CONSISTING OF DOXORUBICIN, CYCLOPHOSPHAMIDE
Details of trial: Protocol Number: ML28714 Study Title: AN INDIAN MULTICENTRIC OPEN LABEL PROSPECTIVE PHASE IV STUDY TO EVALUATE SAFETY AND EFFICACY OF
TRASTUZUMAB
IN HER2 POSITIVE, NODE POSITIVE OR HIGH RISK NODE NEGATIVE BREAST CANCER AS A PART OF TREATMENT REGIMEN CONSISTING OF DOXORUBICIN, CYCLOPHOSPHAMIDE
anshul_15
in
Breast Cancer India
9 years ago
Chemo treatment advice
Now the cancer has spread to my liver and lungs and the treatments I'm being offered is, first, a trial with Xeloda with
Trastuzumab
and if that doesn't help, Irinotecan. The onc assures me that neither of these treatments will affect my PN.
Now the cancer has spread to my liver and lungs and the treatments I'm being offered is, first, a trial with Xeloda with
Trastuzumab
and if that doesn't help, Irinotecan. The onc assures me that neither of these treatments will affect my PN.
Chaskell
in
OPA Palliative Care & Guidance
11 years ago
Treatment advice
Now the cancer has spread to my liver and lungs and the treatments I'm being offered is, first, a trial with Xeloda with
Trastuzumab
and if that doesn't help, Irinotecan. The onc assures me that neither of these treatments will affect my PN.
Now the cancer has spread to my liver and lungs and the treatments I'm being offered is, first, a trial with Xeloda with
Trastuzumab
and if that doesn't help, Irinotecan. The onc assures me that neither of these treatments will affect my PN.
Chaskell
in
Oesophageal & Gastric Cancer
11 years ago
Herceptin
Here is what John says:
Trastuzumab
, or Herceptin was approved by NICE in November 2011. This is a drug that was developed for breast cancer but passed the value for money criteria to be approved for stage 4 metastatic GI cancers if they tested positive for HER2.
Here is what John says:
Trastuzumab
, or Herceptin was approved by NICE in November 2011. This is a drug that was developed for breast cancer but passed the value for money criteria to be approved for stage 4 metastatic GI cancers if they tested positive for HER2.
Hidden
in
Oesophageal & Gastric Cancer
12 years ago
1
...
4
5
Filter results
Clear filters
Posted in
All communities
Breast Cancer India
50 results
SHARE Metastatic Breast Cancer
22 results
Oesophageal & Gastric Cancer
4 results
View top 10 communities
Sort by
Most Relevant
Newest